Show Sources SOURCES: Photo Credit: iStock/Getty Images StatPearls [Internet] : "Compare and Contrast the Glucagon-Like Peptide-1 Receptor Agonists (GLP1RAs)." Diabetes, Obesity, and Metabolism : "Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies." Society of Behavioral Medicine: "What are GLP-1 Medications
When you aim to achieve the same periodic average as the 7-day dosing, with the shorter period, each dose needs to be around 55%-60% of the normal 7-day dose
Well recommend a cadence based on your goals and, where relevant, your labs
Direct human evidence for the KLOW combination does not exist
That said, with clinics like Marek Health it is possible
When they blocked CTGL they observed that that the intracellular GSH concentration dropped to a new steady state of approximately 42% of control in about 24 hours